Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Chemobrain, Cognitive Effects Cancer Treatment

Tim Ahles

PhD

🏢Memorial Sloan Kettering Cancer Center🌐USA

Director, Neurocognitive Research Laboratory

52
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Tim Ahles at MSK has been the leading researcher on cancer-related cognitive impairment (CRCI) — often called 'chemobrain' — the subjective and objective cognitive changes that cancer patients experience during and after treatment. His work characterizing the prevalence, mechanisms (including neuroinflammation, oxidative stress, and hormonal effects), and risk factors for CRCI, and developing cognitive rehabilitation interventions, has been foundational for this important quality-of-life issue.

Share:

🧪Research Fields 研究领域

chemobrain cognitive impairment cancer
chemotherapy cognitive effects
cancer-related cognitive impairment CRCI
post-treatment cognitive changes cancer
breast cancer chemotherapy memory

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-03-01 | All information from publicly available academic sources

关注 Tim Ahles 的研究动态

Follow Tim Ahles's research updates

留下邮箱,当我们发布与 Tim Ahles(Memorial Sloan Kettering Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment